

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.32049155 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 5.32049155 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.11268362 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.11268362 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.79903970 |
| 6 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.42562416 |
| 7 | cysteine metabolic process (GO:0006534) | 4.41246860 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 4.37838674 |
| 9 | protein retention in ER lumen (GO:0006621) | 4.18517977 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 4.17134120 |
| 11 | COPI coating of Golgi vesicle (GO:0048205) | 4.17134120 |
| 12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.02654990 |
| 13 | protein carboxylation (GO:0018214) | 4.00549378 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.00549378 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 4.00178726 |
| 16 | ethanol oxidation (GO:0006069) | 3.87035468 |
| 17 | glyoxylate metabolic process (GO:0046487) | 3.86731542 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.77534449 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 3.75130404 |
| 20 | extracellular fibril organization (GO:0043206) | 3.70050326 |
| 21 | type B pancreatic cell proliferation (GO:0044342) | 3.68573073 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 3.63461919 |
| 23 | barbed-end actin filament capping (GO:0051016) | 3.61622834 |
| 24 | lysine catabolic process (GO:0006554) | 3.49966076 |
| 25 | lysine metabolic process (GO:0006553) | 3.49966076 |
| 26 | valine metabolic process (GO:0006573) | 3.49448569 |
| 27 | intestinal cholesterol absorption (GO:0030299) | 3.46387322 |
| 28 | bile acid biosynthetic process (GO:0006699) | 3.45502857 |
| 29 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.43363166 |
| 30 | regulation of fibrinolysis (GO:0051917) | 3.39013006 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 3.38796740 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34042181 |
| 33 | 4-hydroxyproline metabolic process (GO:0019471) | 3.33430019 |
| 34 | short-chain fatty acid metabolic process (GO:0046459) | 3.30046313 |
| 35 | cellular modified amino acid catabolic process (GO:0042219) | 3.28967810 |
| 36 | regulation of extracellular matrix disassembly (GO:0010715) | 3.26034187 |
| 37 | vesicle coating (GO:0006901) | 3.18948412 |
| 38 | signal peptide processing (GO:0006465) | 3.18230056 |
| 39 | virion assembly (GO:0019068) | 3.16861787 |
| 40 | regulation of cholesterol homeostasis (GO:2000188) | 3.16857895 |
| 41 | kynurenine metabolic process (GO:0070189) | 3.14869393 |
| 42 | regulation of protein activation cascade (GO:2000257) | 3.13670721 |
| 43 | serine family amino acid biosynthetic process (GO:0009070) | 3.13229153 |
| 44 | fibril organization (GO:0097435) | 3.13096384 |
| 45 | fatty acid beta-oxidation (GO:0006635) | 3.12475321 |
| 46 | high-density lipoprotein particle remodeling (GO:0034375) | 3.09224746 |
| 47 | fatty acid catabolic process (GO:0009062) | 3.09068092 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 3.05563828 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 3.05199265 |
| 50 | regulation of autophagic vacuole assembly (GO:2000785) | 3.04638194 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.04154355 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 3.04154355 |
| 53 | indolalkylamine catabolic process (GO:0046218) | 3.04154355 |
| 54 | fatty acid oxidation (GO:0019395) | 3.03316582 |
| 55 | regulation of complement activation (GO:0030449) | 3.00853030 |
| 56 | lipid oxidation (GO:0034440) | 2.98574926 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 2.97195012 |
| 58 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.96435021 |
| 59 | serine family amino acid catabolic process (GO:0009071) | 2.96062890 |
| 60 | complement activation, alternative pathway (GO:0006957) | 2.95494986 |
| 61 | branched-chain amino acid catabolic process (GO:0009083) | 2.94886472 |
| 62 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.94302653 |
| 63 | opsonization (GO:0008228) | 2.94217705 |
| 64 | regulation of cholesterol metabolic process (GO:0090181) | 2.94120449 |
| 65 | ethanol metabolic process (GO:0006067) | 2.92766010 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 2.92651436 |
| 67 | tryptophan metabolic process (GO:0006568) | 2.92516801 |
| 68 | response to nitrosative stress (GO:0051409) | 2.92269133 |
| 69 | COPII vesicle coating (GO:0048208) | 2.92197805 |
| 70 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.92085337 |
| 71 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.92085337 |
| 72 | cellular copper ion homeostasis (GO:0006878) | 2.91219546 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 2.89727586 |
| 74 | branched-chain amino acid metabolic process (GO:0009081) | 2.89479638 |
| 75 | carnitine metabolic process (GO:0009437) | 2.89440254 |
| 76 | coenzyme catabolic process (GO:0009109) | 2.88799688 |
| 77 | regulation of metalloenzyme activity (GO:0048552) | 2.88470149 |
| 78 | GDP-mannose metabolic process (GO:0019673) | 2.88183381 |
| 79 | regulation of cholesterol esterification (GO:0010872) | 2.88100144 |
| 80 | amyloid precursor protein catabolic process (GO:0042987) | 2.88009299 |
| 81 | glycine metabolic process (GO:0006544) | 2.87260332 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 2.86844028 |
| 83 | bile acid metabolic process (GO:0008206) | 2.86253895 |
| 84 | aldehyde catabolic process (GO:0046185) | 2.86014155 |
| 85 | cellular amino acid catabolic process (GO:0009063) | 2.85402999 |
| 86 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.85292709 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 2.84910035 |
| 88 | basement membrane organization (GO:0071711) | 2.84133418 |
| 89 | regulation of triglyceride catabolic process (GO:0010896) | 2.83933891 |
| 90 | eosinophil chemotaxis (GO:0048245) | 2.82865198 |
| 91 | homocysteine metabolic process (GO:0050667) | 2.82288578 |
| 92 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.79995560 |
| 93 | organic acid catabolic process (GO:0016054) | 2.78008250 |
| 94 | carboxylic acid catabolic process (GO:0046395) | 2.78008250 |
| 95 | regulation of plasminogen activation (GO:0010755) | 2.77030271 |
| 96 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.76800283 |
| 97 | heme transport (GO:0015886) | 2.76675665 |
| 98 | skin morphogenesis (GO:0043589) | 2.76339035 |
| 99 | exocrine pancreas development (GO:0031017) | 2.74904536 |
| 100 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.74787999 |
| 101 | response to mercury ion (GO:0046689) | 2.74545824 |
| 102 | regulation of vacuole organization (GO:0044088) | 2.73061477 |
| 103 | acute-phase response (GO:0006953) | 2.72387044 |
| 104 | L-serine metabolic process (GO:0006563) | 2.69724826 |
| 105 | regulation of mononuclear cell migration (GO:0071675) | 2.69628082 |
| 106 | plasma lipoprotein particle remodeling (GO:0034369) | 2.69146728 |
| 107 | protein-lipid complex remodeling (GO:0034368) | 2.69146728 |
| 108 | macromolecular complex remodeling (GO:0034367) | 2.69146728 |
| 109 | positive regulation of TOR signaling (GO:0032008) | 2.68979781 |
| 110 | pentose-phosphate shunt (GO:0006098) | 2.68351044 |
| 111 | fibrinolysis (GO:0042730) | 2.67929953 |
| 112 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.66993641 |
| 113 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.66993641 |
| 114 | peptidyl-proline hydroxylation (GO:0019511) | 2.66566758 |
| 115 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.66488136 |
| 116 | primary alcohol catabolic process (GO:0034310) | 2.65821212 |
| 117 | negative regulation of cholesterol transport (GO:0032375) | 2.65799418 |
| 118 | negative regulation of sterol transport (GO:0032372) | 2.65799418 |
| 119 | reverse cholesterol transport (GO:0043691) | 2.65733574 |
| 120 | biotin metabolic process (GO:0006768) | 2.65644653 |
| 121 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.65298653 |
| 122 | tyrosine metabolic process (GO:0006570) | 2.64648258 |
| 123 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.61924863 |
| 124 | cofactor catabolic process (GO:0051187) | 2.61782979 |
| 125 | tricarboxylic acid metabolic process (GO:0072350) | 2.61466926 |
| 126 | 2-oxoglutarate metabolic process (GO:0006103) | 2.60915059 |
| 127 | L-serine transport (GO:0015825) | 2.59475166 |
| 128 | proline biosynthetic process (GO:0006561) | 2.58123764 |
| 129 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.57341051 |
| 130 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.52819074 |
| 131 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.51998831 |
| 132 | glucose 6-phosphate metabolic process (GO:0051156) | 2.51551177 |
| 133 | actin filament depolymerization (GO:0030042) | 2.51267178 |
| 134 | positive regulation of pseudopodium assembly (GO:0031274) | 2.50339904 |
| 135 | glucose catabolic process (GO:0006007) | 2.49528939 |
| 136 | NADPH regeneration (GO:0006740) | 2.48909650 |
| 137 | eosinophil migration (GO:0072677) | 2.47982867 |
| 138 | viral protein processing (GO:0019082) | 2.46696040 |
| 139 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.46640284 |
| 140 | protein insertion into membrane (GO:0051205) | 2.46272083 |
| 141 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.45507342 |
| 142 | positive regulation of mitochondrial fission (GO:0090141) | 2.45234447 |
| 143 | serine transport (GO:0032329) | 2.42213774 |
| 144 | fatty acid elongation (GO:0030497) | 2.42101812 |
| 145 | response to gravity (GO:0009629) | 2.36102627 |
| 146 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.32481864 |
| 147 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.32481864 |
| 148 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.32481864 |
| 149 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.32036699 |
| 150 | ganglion development (GO:0061548) | 2.29805966 |
| 151 | galactose catabolic process (GO:0019388) | 2.29541255 |
| 152 | cell adhesion mediated by integrin (GO:0033627) | 2.28869233 |
| 153 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.27691841 |
| 154 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.27553155 |
| 155 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.27553155 |
| 156 | positive regulation of actin filament depolymerization (GO:0030836) | 2.27382417 |
| 157 | protein hydroxylation (GO:0018126) | 2.27112690 |
| 158 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.26527780 |
| 159 | maintenance of protein localization in organelle (GO:0072595) | 2.23314345 |
| 160 | transferrin transport (GO:0033572) | 2.23287983 |
| 161 | membrane budding (GO:0006900) | 2.23094838 |
| 162 | phagosome maturation (GO:0090382) | 2.21846956 |
| 163 | amino sugar catabolic process (GO:0046348) | 2.20677898 |
| 164 | protein localization to endosome (GO:0036010) | 2.20022480 |
| 165 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.17988440 |
| 166 | proteasome assembly (GO:0043248) | 2.16038462 |
| 167 | regulation of pseudopodium assembly (GO:0031272) | 2.14121406 |
| 168 | positive regulation of nuclease activity (GO:0032075) | 2.13557185 |
| 169 | morphogenesis of an endothelium (GO:0003159) | 2.12961903 |
| 170 | endothelial tube morphogenesis (GO:0061154) | 2.12961903 |
| 171 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.11279792 |
| 172 | beta-amyloid metabolic process (GO:0050435) | 2.10803345 |
| 173 | negative regulation of Ras GTPase activity (GO:0034261) | 2.10457964 |
| 174 | galactose metabolic process (GO:0006012) | 2.09305272 |
| 175 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.09016819 |
| 176 | platelet degranulation (GO:0002576) | 2.08144038 |
| 177 | muscle cell migration (GO:0014812) | 2.07412620 |
| 178 | metallo-sulfur cluster assembly (GO:0031163) | 2.06343160 |
| 179 | iron-sulfur cluster assembly (GO:0016226) | 2.06343160 |
| 180 | monosaccharide biosynthetic process (GO:0046364) | 2.06045637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.46406966 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.52852249 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.31411647 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.13594581 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15913664 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.89481170 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.85009793 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.69723985 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.60428832 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.53221958 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17629710 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15202651 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07739529 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95065158 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91924536 |
| 16 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.86754192 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.86113471 |
| 18 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.84728261 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84515191 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.84240891 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84035134 |
| 22 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.82533955 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68404767 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65109021 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63349220 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63260705 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61309356 |
| 28 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.61085968 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.58384655 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53712080 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48996404 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48486125 |
| 33 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.47730883 |
| 34 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47193594 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.46461988 |
| 36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.45086965 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43875207 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43410649 |
| 39 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.42594009 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42327157 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42187189 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41657224 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41435114 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.39858039 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39217564 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34310161 |
| 47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31671465 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.30050550 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28466256 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.28209807 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27902163 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27901586 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24640139 |
| 54 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.24320791 |
| 55 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23907570 |
| 56 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.23824460 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22902504 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20657590 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20015900 |
| 60 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19685354 |
| 61 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18184866 |
| 62 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.16459143 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16070952 |
| 64 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14496369 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14131695 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13717588 |
| 67 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.13629132 |
| 68 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13491196 |
| 69 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12843720 |
| 70 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.12758958 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.12533272 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11703025 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11543713 |
| 74 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11254693 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10522513 |
| 76 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.10478793 |
| 77 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09350086 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07235888 |
| 79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07170332 |
| 80 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.06789604 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05298859 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05213997 |
| 83 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.04754181 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04367326 |
| 85 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03844198 |
| 86 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.03830881 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03462757 |
| 88 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.02940412 |
| 89 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02924524 |
| 90 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02702346 |
| 91 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02180286 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.01795214 |
| 93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.01721859 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01703233 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 1.01579844 |
| 96 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.00884691 |
| 97 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.00228014 |
| 98 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00203613 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99490226 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98962564 |
| 101 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98653146 |
| 102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98451404 |
| 103 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98201873 |
| 104 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.97004817 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 0.96513977 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96455884 |
| 107 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96350427 |
| 108 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.96154161 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94765547 |
| 110 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94637198 |
| 111 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94625183 |
| 112 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93394326 |
| 113 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92750076 |
| 114 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.92701995 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92558146 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92423282 |
| 117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92173138 |
| 118 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91074716 |
| 119 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88972910 |
| 120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88467361 |
| 121 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87457469 |
| 122 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.87374907 |
| 123 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87347913 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87088241 |
| 125 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86956275 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86835610 |
| 127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86346905 |
| 128 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86063118 |
| 129 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.85596655 |
| 130 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85318392 |
| 131 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85194568 |
| 132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.84786431 |
| 133 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84090216 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83640644 |
| 135 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.83447849 |
| 136 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82777270 |
| 137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82734349 |
| 138 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.81439382 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81267987 |
| 140 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81099560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.34214818 |
| 2 | MP0009840_abnormal_foam_cell | 4.55997182 |
| 3 | MP0005365_abnormal_bile_salt | 3.97517667 |
| 4 | MP0005360_urolithiasis | 3.96360523 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.19685083 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.18522696 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.04540245 |
| 8 | MP0005257_abnormal_intraocular_pressure | 2.80984015 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.77428039 |
| 10 | MP0005083_abnormal_biliary_tract | 2.72592018 |
| 11 | MP0003122_maternal_imprinting | 2.71883772 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.61428743 |
| 13 | MP0003195_calcinosis | 2.52997736 |
| 14 | MP0000566_synostosis | 2.40014629 |
| 15 | MP0008260_abnormal_autophagy | 2.20587927 |
| 16 | MP0005332_abnormal_amino_acid | 2.19675817 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.15525261 |
| 18 | MP0003252_abnormal_bile_duct | 2.11025631 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.07157999 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.98346149 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.96262609 |
| 22 | MP0005220_abnormal_exocrine_pancreas | 1.95794383 |
| 23 | MP0010030_abnormal_orbit_morphology | 1.84094702 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.81974767 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.80563934 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.79873322 |
| 27 | MP0002653_abnormal_ependyma_morphology | 1.72632783 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.68365169 |
| 29 | MP0000609_abnormal_liver_physiology | 1.58979831 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.58284276 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.56792553 |
| 32 | MP0000751_myopathy | 1.56400144 |
| 33 | MP0003724_increased_susceptibility_to | 1.55906605 |
| 34 | MP0005171_absent_coat_pigmentation | 1.52814890 |
| 35 | MP0004510_myositis | 1.51423971 |
| 36 | MP0005451_abnormal_body_composition | 1.51195828 |
| 37 | MP0003279_aneurysm | 1.51027832 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.48333749 |
| 39 | MP0005275_abnormal_skin_tensile | 1.48224571 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46603249 |
| 41 | MP0003186_abnormal_redox_activity | 1.45836667 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.43674019 |
| 43 | MP0005367_renal/urinary_system_phenotyp | 1.43538479 |
| 44 | MP0000516_abnormal_urinary_system | 1.43538479 |
| 45 | MP0003011_delayed_dark_adaptation | 1.43224930 |
| 46 | MP0003123_paternal_imprinting | 1.41326889 |
| 47 | MP0003868_abnormal_feces_composition | 1.41235387 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.38053678 |
| 49 | MP0004858_abnormal_nervous_system | 1.36533541 |
| 50 | MP0001849_ear_inflammation | 1.35830907 |
| 51 | MP0001542_abnormal_bone_strength | 1.31503374 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.31263645 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.26104569 |
| 54 | MP0003075_altered_response_to | 1.26008427 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.23783505 |
| 56 | MP0004043_abnormal_pH_regulation | 1.23770210 |
| 57 | MP0003436_decreased_susceptibility_to | 1.20623997 |
| 58 | MP0001958_emphysema | 1.18794461 |
| 59 | MP0006054_spinal_hemorrhage | 1.18553949 |
| 60 | MP0004133_heterotaxia | 1.16481545 |
| 61 | MP0005508_abnormal_skeleton_morphology | 1.15692382 |
| 62 | MP0000534_abnormal_ureter_morphology | 1.15344198 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.13262761 |
| 64 | MP0001756_abnormal_urination | 1.12020352 |
| 65 | MP0005503_abnormal_tendon_morphology | 1.10902569 |
| 66 | MP0000538_abnormal_urinary_bladder | 1.10625644 |
| 67 | MP0001944_abnormal_pancreas_morphology | 1.09764425 |
| 68 | MP0002933_joint_inflammation | 1.09549984 |
| 69 | MP0001905_abnormal_dopamine_level | 1.08173338 |
| 70 | MP0008469_abnormal_protein_level | 1.07940134 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 1.06848416 |
| 72 | MP0010368_abnormal_lymphatic_system | 1.05537350 |
| 73 | MP0000685_abnormal_immune_system | 1.04857170 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.04703554 |
| 75 | MP0005623_abnormal_meninges_morphology | 1.04517083 |
| 76 | MP0003942_abnormal_urinary_system | 1.04118217 |
| 77 | MP0008789_abnormal_olfactory_epithelium | 1.02432717 |
| 78 | MP0005408_hypopigmentation | 1.02315059 |
| 79 | MP0005464_abnormal_platelet_physiology | 1.01844999 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 1.01169041 |
| 81 | MP0005390_skeleton_phenotype | 1.00904410 |
| 82 | MP0000598_abnormal_liver_morphology | 0.99600170 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.95722197 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.95608044 |
| 85 | MP0002060_abnormal_skin_morphology | 0.94839094 |
| 86 | MP0005023_abnormal_wound_healing | 0.94325762 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.93175035 |
| 88 | MP0001915_intracranial_hemorrhage | 0.93055305 |
| 89 | MP0001529_abnormal_vocalization | 0.92736574 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.92351231 |
| 91 | MP0000750_abnormal_muscle_regeneration | 0.92269195 |
| 92 | MP0009764_decreased_sensitivity_to | 0.91842692 |
| 93 | MP0001764_abnormal_homeostasis | 0.91758862 |
| 94 | MP0002736_abnormal_nociception_after | 0.91486663 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.89915862 |
| 96 | MP0001270_distended_abdomen | 0.89143059 |
| 97 | MP0005164_abnormal_response_to | 0.88736106 |
| 98 | MP0006082_CNS_inflammation | 0.87926004 |
| 99 | MP0005165_increased_susceptibility_to | 0.86821034 |
| 100 | MP0000681_abnormal_thyroid_gland | 0.86601950 |
| 101 | MP0009379_abnormal_foot_pigmentation | 0.86052794 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.86045376 |
| 103 | MP0005670_abnormal_white_adipose | 0.85941232 |
| 104 | MP0003329_amyloid_beta_deposits | 0.85102806 |
| 105 | MP0004264_abnormal_extraembryonic_tissu | 0.85079007 |
| 106 | MP0009785_altered_susceptibility_to | 0.84451372 |
| 107 | MP0000858_altered_metastatic_potential | 0.84414165 |
| 108 | MP0003283_abnormal_digestive_organ | 0.83689044 |
| 109 | MP0001765_abnormal_ion_homeostasis | 0.83500500 |
| 110 | MP0003121_genomic_imprinting | 0.83065300 |
| 111 | MP0001243_abnormal_dermal_layer | 0.82594288 |
| 112 | MP0009763_increased_sensitivity_to | 0.81789183 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81724106 |
| 114 | MP0000604_amyloidosis | 0.81228905 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.80877156 |
| 116 | MP0004272_abnormal_basement_membrane | 0.80865152 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.80630627 |
| 118 | MP0009642_abnormal_blood_homeostasis | 0.79788608 |
| 119 | MP0003879_abnormal_hair_cell | 0.78085904 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.77781695 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.77431381 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.77280101 |
| 123 | MP0004130_abnormal_muscle_cell | 0.76405303 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.75087857 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.74576523 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.74426018 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.73658662 |
| 128 | MP0003303_peritoneal_inflammation | 0.73519565 |
| 129 | MP0005166_decreased_susceptibility_to | 0.73331388 |
| 130 | MP0000467_abnormal_esophagus_morphology | 0.72041739 |
| 131 | MP0000613_abnormal_salivary_gland | 0.71907881 |
| 132 | MP0009333_abnormal_splenocyte_physiolog | 0.71891222 |
| 133 | MP0005197_abnormal_uvea_morphology | 0.71433706 |
| 134 | MP0001663_abnormal_digestive_system | 0.70975576 |
| 135 | MP0004270_analgesia | 0.70640080 |
| 136 | MP0002822_catalepsy | 0.69854729 |
| 137 | MP0000343_altered_response_to | 0.68595184 |
| 138 | MP0002254_reproductive_system_inflammat | 0.68461461 |
| 139 | MP0002277_abnormal_respiratory_mucosa | 0.68064529 |
| 140 | MP0001790_abnormal_immune_system | 0.67902223 |
| 141 | MP0005387_immune_system_phenotype | 0.67902223 |
| 142 | MP0005025_abnormal_response_to | 0.67710434 |
| 143 | MP0002089_abnormal_postnatal_growth/wei | 0.66929965 |
| 144 | MP0002796_impaired_skin_barrier | 0.66674405 |
| 145 | MP0002751_abnormal_autonomic_nervous | 0.66237316 |
| 146 | MP0004947_skin_inflammation | 0.66001594 |
| 147 | MP0005595_abnormal_vascular_smooth | 0.65935682 |
| 148 | MP0005381_digestive/alimentary_phenotyp | 0.65544107 |
| 149 | MP0002876_abnormal_thyroid_physiology | 0.65107451 |
| 150 | MP0003634_abnormal_glial_cell | 0.63604717 |
| 151 | MP0000358_abnormal_cell_content/ | 0.63483307 |
| 152 | MP0003959_abnormal_lean_body | 0.63450735 |
| 153 | MP0002909_abnormal_adrenal_gland | 0.61995774 |
| 154 | MP0000003_abnormal_adipose_tissue | 0.61648839 |
| 155 | MP0005501_abnormal_skin_physiology | 0.58299558 |
| 156 | MP0002896_abnormal_bone_mineralization | 0.57662993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.37182118 |
| 2 | Xanthomatosis (HP:0000991) | 4.23667514 |
| 3 | Hand muscle atrophy (HP:0009130) | 4.01888410 |
| 4 | Hypoglycemic coma (HP:0001325) | 3.88624343 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.87014320 |
| 6 | Protrusio acetabuli (HP:0003179) | 3.76222082 |
| 7 | Cutaneous melanoma (HP:0012056) | 3.69634181 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 3.68315874 |
| 9 | Cervical subluxation (HP:0003308) | 3.62530282 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.59384797 |
| 11 | Distal upper limb amyotrophy (HP:0007149) | 3.54542969 |
| 12 | Upper limb amyotrophy (HP:0009129) | 3.54542969 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 3.50541373 |
| 14 | Cholecystitis (HP:0001082) | 3.50541373 |
| 15 | Ketosis (HP:0001946) | 3.47784136 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.43003935 |
| 17 | Premature rupture of membranes (HP:0001788) | 3.42497967 |
| 18 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29137937 |
| 19 | Ketoacidosis (HP:0001993) | 3.23595584 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.22641344 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.19977852 |
| 22 | Late onset (HP:0003584) | 3.14761042 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.10665548 |
| 24 | Prolonged neonatal jaundice (HP:0006579) | 3.06307015 |
| 25 | Hyperammonemia (HP:0001987) | 3.00634880 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.95006089 |
| 27 | Hyperglycinuria (HP:0003108) | 2.93911617 |
| 28 | J-shaped sella turcica (HP:0002680) | 2.85493618 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.83676999 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 2.83676999 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.75039463 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70852442 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70700690 |
| 34 | Abnormality of dentin (HP:0010299) | 2.70394748 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.69696785 |
| 36 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68458362 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68458362 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68458362 |
| 39 | Hypobetalipoproteinemia (HP:0003563) | 2.66428538 |
| 40 | Hyperglycinemia (HP:0002154) | 2.66111792 |
| 41 | Short nail (HP:0001799) | 2.64737074 |
| 42 | Upper limb muscle weakness (HP:0003484) | 2.59950713 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.56150026 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56150026 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 2.54021851 |
| 46 | Loss of speech (HP:0002371) | 2.52316147 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.50327308 |
| 48 | Fat malabsorption (HP:0002630) | 2.47755459 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47494608 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.47494608 |
| 51 | Hypoglycemic seizures (HP:0002173) | 2.45296572 |
| 52 | Hypolipoproteinemia (HP:0010981) | 2.45193943 |
| 53 | Gout (HP:0001997) | 2.42496157 |
| 54 | Complement deficiency (HP:0004431) | 2.42314822 |
| 55 | Beaking of vertebral bodies (HP:0004568) | 2.40972924 |
| 56 | Atrophic scars (HP:0001075) | 2.38485734 |
| 57 | Peritonitis (HP:0002586) | 2.32738080 |
| 58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.30866029 |
| 59 | Progressive neurologic deterioration (HP:0002344) | 2.29953057 |
| 60 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.28718545 |
| 61 | Polyphagia (HP:0002591) | 2.28104082 |
| 62 | Joint hemorrhage (HP:0005261) | 2.26073786 |
| 63 | Abnormal hemoglobin (HP:0011902) | 2.22754859 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21912842 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21912842 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21912842 |
| 67 | Menorrhagia (HP:0000132) | 2.18476975 |
| 68 | Steatorrhea (HP:0002570) | 2.18191223 |
| 69 | Malnutrition (HP:0004395) | 2.17836870 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.17591524 |
| 71 | Joint stiffness (HP:0001387) | 2.16382518 |
| 72 | Ovoid vertebral bodies (HP:0003300) | 2.16200285 |
| 73 | Abnormality of complement system (HP:0005339) | 2.15576549 |
| 74 | Nonimmune hydrops fetalis (HP:0001790) | 2.14459091 |
| 75 | Vascular tortuosity (HP:0004948) | 2.14036129 |
| 76 | Hyperbilirubinemia (HP:0002904) | 2.11567804 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11388894 |
| 78 | Biconcave vertebral bodies (HP:0004586) | 2.11357847 |
| 79 | Congenital glaucoma (HP:0001087) | 2.11295110 |
| 80 | Myocardial infarction (HP:0001658) | 2.10354698 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.09527554 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.09527554 |
| 83 | Mitral stenosis (HP:0001718) | 2.06438509 |
| 84 | Pancreatitis (HP:0001733) | 2.05922532 |
| 85 | Protuberant abdomen (HP:0001538) | 2.05286853 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 2.05274621 |
| 87 | Increased serum ferritin (HP:0003281) | 2.04469724 |
| 88 | Methylmalonic aciduria (HP:0012120) | 2.03808954 |
| 89 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.02564895 |
| 90 | Delayed CNS myelination (HP:0002188) | 2.01002600 |
| 91 | Opisthotonus (HP:0002179) | 1.99039027 |
| 92 | Arterial tortuosity (HP:0005116) | 1.98567606 |
| 93 | Nuclear cataract (HP:0100018) | 1.97697899 |
| 94 | Metabolic acidosis (HP:0001942) | 1.97584386 |
| 95 | Spinal rigidity (HP:0003306) | 1.97557382 |
| 96 | Hepatic necrosis (HP:0002605) | 1.96743551 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96035630 |
| 98 | Petechiae (HP:0000967) | 1.95969004 |
| 99 | Lethargy (HP:0001254) | 1.92216583 |
| 100 | Growth hormone excess (HP:0000845) | 1.92204382 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 1.92157153 |
| 102 | Abdominal distention (HP:0003270) | 1.91585843 |
| 103 | Amyloidosis (HP:0011034) | 1.90460236 |
| 104 | Follicular hyperkeratosis (HP:0007502) | 1.90345611 |
| 105 | Cardiovascular calcification (HP:0011915) | 1.89432706 |
| 106 | Purpura (HP:0000979) | 1.89402676 |
| 107 | Abnormality of serum amino acid levels (HP:0003112) | 1.89023952 |
| 108 | Vascular calcification (HP:0004934) | 1.88216255 |
| 109 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87856383 |
| 110 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87856383 |
| 111 | Abnormal protein glycosylation (HP:0012346) | 1.87856383 |
| 112 | Abnormal glycosylation (HP:0012345) | 1.87856383 |
| 113 | Abnormality of macrophages (HP:0004311) | 1.87583269 |
| 114 | Abnormality of iron homeostasis (HP:0011031) | 1.86976275 |
| 115 | Abnormality of glycolysis (HP:0004366) | 1.86449500 |
| 116 | Blue sclerae (HP:0000592) | 1.86259573 |
| 117 | Lymphangioma (HP:0100764) | 1.85983776 |
| 118 | Epiphyseal stippling (HP:0010655) | 1.85981763 |
| 119 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85134714 |
| 120 | Insulin resistance (HP:0000855) | 1.84435139 |
| 121 | Heterochromia iridis (HP:0001100) | 1.83427826 |
| 122 | Hypokinesia (HP:0002375) | 1.82584841 |
| 123 | Vomiting (HP:0002013) | 1.82104346 |
| 124 | Abnormality of methionine metabolism (HP:0010901) | 1.82091867 |
| 125 | Axonal loss (HP:0003447) | 1.81393856 |
| 126 | Systemic lupus erythematosus (HP:0002725) | 1.80485978 |
| 127 | Brushfield spots (HP:0001088) | 1.80456204 |
| 128 | Hypoventilation (HP:0002791) | 1.80442127 |
| 129 | Increased serum pyruvate (HP:0003542) | 1.80297284 |
| 130 | Irritability (HP:0000737) | 1.79768975 |
| 131 | Wormian bones (HP:0002645) | 1.78879974 |
| 132 | Achilles tendon contracture (HP:0001771) | 1.78334051 |
| 133 | Polycythemia (HP:0001901) | 1.78160274 |
| 134 | Abnormal delivery (HP:0001787) | 1.77060187 |
| 135 | Symptomatic seizures (HP:0011145) | 1.76886450 |
| 136 | Hyperglycemia (HP:0003074) | 1.76321570 |
| 137 | Pulmonary artery stenosis (HP:0004415) | 1.75964797 |
| 138 | Ectopia lentis (HP:0001083) | 1.75866257 |
| 139 | Hepatosplenomegaly (HP:0001433) | 1.75172967 |
| 140 | Type I transferrin isoform profile (HP:0003642) | 1.74793397 |
| 141 | Aortic dissection (HP:0002647) | 1.73980536 |
| 142 | Slender build (HP:0001533) | 1.73841951 |
| 143 | Distal lower limb muscle weakness (HP:0009053) | 1.73252820 |
| 144 | Asymmetric septal hypertrophy (HP:0001670) | 1.73207489 |
| 145 | Soft skin (HP:0000977) | 1.72511580 |
| 146 | Alkalosis (HP:0001948) | 1.72230423 |
| 147 | Increased muscle lipid content (HP:0009058) | 1.71187099 |
| 148 | Conjugated hyperbilirubinemia (HP:0002908) | 1.70962906 |
| 149 | Back pain (HP:0003418) | 1.70873657 |
| 150 | Generalized amyotrophy (HP:0003700) | 1.68471523 |
| 151 | Osteopenia (HP:0000938) | 1.67206452 |
| 152 | Supranuclear gaze palsy (HP:0000605) | 1.67078796 |
| 153 | Episodic fever (HP:0001954) | 1.65945289 |
| 154 | Abnormality of urine glucose concentration (HP:0011016) | 1.65930937 |
| 155 | Glycosuria (HP:0003076) | 1.65930937 |
| 156 | Abnormal gallbladder morphology (HP:0012437) | 1.65505315 |
| 157 | Gingival bleeding (HP:0000225) | 1.65076761 |
| 158 | Microglossia (HP:0000171) | 1.64948777 |
| 159 | Ankle contracture (HP:0006466) | 1.63502017 |
| 160 | Cholelithiasis (HP:0001081) | 1.62142609 |
| 161 | Abnormality of carpal bone ossification (HP:0006257) | 1.61637089 |
| 162 | Bladder diverticulum (HP:0000015) | 1.61470635 |
| 163 | Cerebral palsy (HP:0100021) | 1.59391815 |
| 164 | Muscle fibrillation (HP:0010546) | 1.56734343 |
| 165 | Craniofacial dystonia (HP:0012179) | 1.55756155 |
| 166 | Fragile skin (HP:0001030) | 1.55609754 |
| 167 | Long foot (HP:0001833) | 1.54653122 |
| 168 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.54154725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.50195293 |
| 2 | BCKDK | 4.59952673 |
| 3 | TAOK2 | 3.90521156 |
| 4 | TRIB3 | 3.73639845 |
| 5 | TAOK3 | 3.03018138 |
| 6 | NME2 | 2.95150476 |
| 7 | MAPK15 | 2.67147631 |
| 8 | FGFR4 | 2.24121684 |
| 9 | EPHB1 | 2.13398295 |
| 10 | SIK1 | 2.08392279 |
| 11 | KDR | 2.04465730 |
| 12 | PKN2 | 2.02699246 |
| 13 | PIM2 | 1.97587329 |
| 14 | VRK2 | 1.97226294 |
| 15 | FLT3 | 1.91920361 |
| 16 | EPHA3 | 1.88172914 |
| 17 | MAP4K2 | 1.82002449 |
| 18 | LMTK2 | 1.78909470 |
| 19 | TBK1 | 1.72018502 |
| 20 | BLK | 1.70320111 |
| 21 | MAP2K2 | 1.69992206 |
| 22 | TESK2 | 1.67068604 |
| 23 | NLK | 1.65414062 |
| 24 | ZAP70 | 1.58600488 |
| 25 | SIK3 | 1.57248153 |
| 26 | MAP4K1 | 1.52874068 |
| 27 | WNK4 | 1.44175344 |
| 28 | IRAK3 | 1.40731917 |
| 29 | PIK3CG | 1.31864107 |
| 30 | MAP3K11 | 1.28631288 |
| 31 | TGFBR2 | 1.25408721 |
| 32 | INSRR | 1.22233424 |
| 33 | CSK | 1.19594754 |
| 34 | BCR | 1.17570345 |
| 35 | LRRK2 | 1.14298214 |
| 36 | NEK9 | 1.13685881 |
| 37 | TYK2 | 1.10435182 |
| 38 | MAP2K7 | 1.06069610 |
| 39 | PRKD2 | 1.02595465 |
| 40 | DAPK3 | 1.01555062 |
| 41 | MAP3K12 | 0.99143687 |
| 42 | TAOK1 | 0.98150768 |
| 43 | IRAK1 | 0.97871560 |
| 44 | CSNK1A1L | 0.97415960 |
| 45 | FER | 0.96353074 |
| 46 | MKNK2 | 0.95931816 |
| 47 | PTK6 | 0.94297814 |
| 48 | DYRK1B | 0.94187283 |
| 49 | SCYL2 | 0.90743651 |
| 50 | JAK3 | 0.90628986 |
| 51 | MAP3K1 | 0.90405104 |
| 52 | CSNK1G2 | 0.88223978 |
| 53 | ABL2 | 0.87063015 |
| 54 | CDK19 | 0.85878845 |
| 55 | PTK2 | 0.85525452 |
| 56 | MAPKAPK3 | 0.85327496 |
| 57 | MYLK | 0.85121454 |
| 58 | DAPK1 | 0.83930800 |
| 59 | MARK1 | 0.81342728 |
| 60 | IKBKE | 0.80741433 |
| 61 | TRIM28 | 0.78903973 |
| 62 | EPHB2 | 0.78444645 |
| 63 | HIPK2 | 0.77470157 |
| 64 | MET | 0.75604022 |
| 65 | JAK1 | 0.75570838 |
| 66 | EIF2AK1 | 0.75517583 |
| 67 | STK16 | 0.74831716 |
| 68 | PRKG2 | 0.74674149 |
| 69 | ICK | 0.74509902 |
| 70 | MST4 | 0.74362664 |
| 71 | CSNK1G1 | 0.73795242 |
| 72 | MAP3K7 | 0.73547061 |
| 73 | BTK | 0.71873685 |
| 74 | DYRK2 | 0.71858252 |
| 75 | EPHA2 | 0.67548754 |
| 76 | PAK4 | 0.67479461 |
| 77 | MAP3K3 | 0.65063846 |
| 78 | MAP2K3 | 0.64739306 |
| 79 | RPS6KA4 | 0.64104786 |
| 80 | ROCK2 | 0.63660415 |
| 81 | SIK2 | 0.63477026 |
| 82 | ILK | 0.63438614 |
| 83 | STK38 | 0.62059968 |
| 84 | BMX | 0.60551319 |
| 85 | PAK6 | 0.60499198 |
| 86 | RIPK1 | 0.59887145 |
| 87 | GRK5 | 0.59809700 |
| 88 | PTK2B | 0.57704884 |
| 89 | TESK1 | 0.57149151 |
| 90 | MAPK4 | 0.55686781 |
| 91 | KIT | 0.54734478 |
| 92 | TTN | 0.54699996 |
| 93 | ADRBK1 | 0.54336046 |
| 94 | DYRK3 | 0.53137136 |
| 95 | GRK6 | 0.52516722 |
| 96 | PRKD1 | 0.52167785 |
| 97 | PDGFRA | 0.51207476 |
| 98 | MAPK11 | 0.49741638 |
| 99 | JAK2 | 0.49106557 |
| 100 | PAK3 | 0.47345843 |
| 101 | CDK6 | 0.46823622 |
| 102 | CDK14 | 0.46465217 |
| 103 | ROCK1 | 0.46399991 |
| 104 | NME1 | 0.46184600 |
| 105 | PAK2 | 0.45026449 |
| 106 | GSK3A | 0.44898637 |
| 107 | RET | 0.43529925 |
| 108 | PIK3CA | 0.43377029 |
| 109 | PAK1 | 0.43212413 |
| 110 | STK39 | 0.42846699 |
| 111 | MAPK12 | 0.42709213 |
| 112 | DYRK1A | 0.41224154 |
| 113 | MAPKAPK2 | 0.40726462 |
| 114 | ARAF | 0.40662924 |
| 115 | MAP2K1 | 0.40612700 |
| 116 | ITK | 0.40005584 |
| 117 | PRKCI | 0.39670681 |
| 118 | GRK7 | 0.39089392 |
| 119 | MAP3K8 | 0.38985492 |
| 120 | PINK1 | 0.38423634 |
| 121 | CDK4 | 0.37997755 |
| 122 | TEC | 0.37588341 |
| 123 | NTRK1 | 0.37182438 |
| 124 | CSNK1G3 | 0.36726244 |
| 125 | IKBKB | 0.35187982 |
| 126 | CAMK2G | 0.34994461 |
| 127 | MARK2 | 0.34489555 |
| 128 | LIMK1 | 0.34428757 |
| 129 | MST1R | 0.34036977 |
| 130 | CDK18 | 0.32910776 |
| 131 | SRPK1 | 0.30935317 |
| 132 | PRKCZ | 0.30906478 |
| 133 | SRC | 0.30662336 |
| 134 | EEF2K | 0.30254189 |
| 135 | IRAK2 | 0.29609905 |
| 136 | RPS6KA2 | 0.29219416 |
| 137 | CDK15 | 0.29029420 |
| 138 | CDK11A | 0.28946001 |
| 139 | STK10 | 0.28062075 |
| 140 | CDK9 | 0.27712805 |
| 141 | MAP3K6 | 0.26176858 |
| 142 | MAPKAPK5 | 0.26045160 |
| 143 | MAP3K5 | 0.25132338 |
| 144 | DDR2 | 0.24180198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.12502485 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.84902399 |
| 3 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.68165233 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63972041 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.57125978 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54463047 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.47908219 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38255279 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.36579461 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.33057714 |
| 11 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.22409172 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20099975 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.09853251 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05999566 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.99235798 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90494788 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84756375 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.83020419 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.82763675 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81429571 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79692588 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.78757229 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74029081 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73838949 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70547281 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69382921 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66544928 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.60826264 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56642789 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56424508 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55677260 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54341960 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.53461800 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49708567 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.48031930 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47435863 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.47390509 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46338226 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41444991 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38362490 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.36602627 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33647600 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31164784 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30743311 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.30530649 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26602320 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25243096 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22291143 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22034898 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21735809 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17696855 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12353582 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09816053 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08956236 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07671582 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06910902 |
| 57 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.06411493 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06373789 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05850093 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 1.05639295 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04639553 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04230679 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 1.04193272 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03092101 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02698295 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01935579 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97635027 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97079459 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.96073288 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95178876 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90318320 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89450597 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.87084876 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84584663 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83905915 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81459813 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80852390 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.80186360 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79656026 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.76805978 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.74891623 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72883732 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71130555 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69647573 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67402679 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67210231 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66244965 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59944896 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.58798508 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58585984 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55553981 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51497910 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48823947 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.48528700 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48396098 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.47535006 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.45593571 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45292202 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45198191 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44432119 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43246298 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42777987 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.42360963 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42013740 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41956169 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41351101 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40997565 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.40360377 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38570332 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.36888209 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.36291924 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31828871 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.30415506 |
| 114 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29871769 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29049172 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.28997483 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28122459 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27552578 |
| 119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.23054191 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.21784777 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20929108 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19382397 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18735288 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.17385252 |
| 125 | Alzheimers disease_Homo sapiens_hsa05010 | 0.15132546 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13356751 |

